Skip to content
healthcare.dev

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial

NDC 62032-914, Hydroquinone, Homosalate, Octisalate, Zinc Oxide, kit, from Obagi Cosmeceuticals LLC.

Product NDC
62032-914
Status
Listed
Labeler
Obagi Cosmeceuticals LLC
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62032-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
62032-914-01620320914011 KIT in 1 KIT (62032-914-01) * 57 g in 1 BOTTLE, PLASTIC (62032-101-36) * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 TUBE (62032-140-05) * 59 mL in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/219c68dc-1e74-4136-9065-85466008d445

Use it

Look up 62032-914 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62032-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62032-914. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.